Date: 2023-06-29Category: Not ApplicableState: Union GovernmentCountry: Europe
Decision of the EEA Joint Committee No 304/2022 of 9 December 2022 amending Annex II (Technical regulations, standards, testing and certification) to the EEA Agreement [2023/1246]
**Summary:**
EEA Joint Committee Decision No. 304/2022, dated 9 December 2022, amends Annex II (Technical regulations, standards, testing and certification) to the EEA Agreement. The decision incorporates Commission Implementing Decision (EU) 2022/1316 of 25 July 2022, which amends Decision 2008/911/EC establishing a list of herbal substances, preparations, and combinations thereof for use in traditional herbal medicinal products, into the EEA Agreement. Specifically, it adds reference "32022 D 1316: Commission Implementing Decision (EU) 2022/1316 of 25 July 2022 (OJ L 198, 27.7.2022, p. 22)" to point 15zl (Commission Decision 2008/911/EC) of Chapter XIII of Annex II. The authentic Icelandic and Norwegian language texts of Implementing Decision (EU) 2022/1316 will be published in the EEA Supplement to the Official Journal of the European Union. The decision entered into force on 10 December 2022, contingent upon completion of all notifications required under Article 103(1) of the EEA Agreement. The decision was published in the EEA Section of, and in the EEA Supplement to, the Official Journal of the European Union.
Key Entities Referenced
EEA Joint Committee: The decision-making body responsible for the EEA Agreement.
EEA Agreement: The Agreement on the European Economic Area.
Annex II to the EEA Agreement: Refers to the Annex containing Technical regulations, standards, testing and certification to the EEA Agreement.
Commission Implementing Decision EU 2022/1316: A specific Commission Implementing Decision amending Decision 2008/911/EC, related to herbal substances.
Decision 2008/911/EC: Establishing a list of herbal substances, preparations and combinations thereof for use in traditional herbal medicinal products.
Article 98 of the EEA Agreement: The specific article of the EEA Agreement that grants the power to the EEA Joint Committee.
Article 103(1) of the EEA Agreement: Article relating to notifications required for the Decision to enter into force.
Brussels: The location where the decision was made.
L 164/28 EN Official Journal of the European Union 29.6.2023
DECISION OF THE EEA JOINT COMMITTEE No 304/2022
of 9 December 2022
amending Annex II (Technical regulations, standards, testing and certification) to the EEA Agreement
[2023/1246]
THE EEA JOINT COMMITTEE,
Having regard to the Agreement on the European Economic Area (“the EEA Agreement”), and in particular Article 98
thereof,
Whereas:
(1) Commission Implementing Decision (EU) 2022/1316 of 25 July 2022 amending Decision 2008/911/EC
establishing a list of herbal substances, preparations and combinations thereof for use in traditional herbal
medicinal products(1)is to be incorporated into the EEA Agreement.
(2) Annex II to the EEA Agreement should therefore be amended accordingly,
HAS ADOPTED THIS DECISION:
Article 1
The following indent is added in point 15zl (Commission Decision 2008/911/EC) of Chapter XIII of Annex II to the EEA
Agreement:
‘— 32022 D 1316: Commission Implementing Decision (EU) 2022/1316 of 25 July 2022(OJ L 198, 27.7.2022, p. 22).’
Article 2
The text of Implementing Decision (EU) 2022/1316 in the Icelandic and Norwegian languages, to be published in the EEA
Supplement to the Official Journal of the European Union, shall be authentic.
Article 3
This Decision shall enter into force on 10 December 2022, provided that all the notifications under Article 103(1) of the
EEA Agreement have been made*.
Article 4
This Decision shall be published in the EEA Section of, and in the EEA Supplement to, the Official Journal of the European
Union.
Done at Brussels, 9 December 2022.
For the EEA Joint Committee
The President
Kristján Andri STEFÁNSSON
(1) OJ L 198, 27.7.2022, p. 22.
* No constitutional requirements indicated.